CONNECT WITH US
Fintech

Fintech

Non-life insurance premium rises 8.9% to Rs 1.8 lakh crore in H1 FY27, health segment leads growth

ET BFSI Fintech logo

Published on

Add as a preferred source on Google
Non-life insurance premium rises 8.9% to Rs 1.8 lakh crore in H1 FY27, health segment leads growth

Non-life insurance premium rises 8.9% to Rs 1.8 lakh crore in H1 FY27, health segment leads growth

Non-life insurers excluding specialised companies recorded 11.74% growth in gross direct premium during April-September, while standalone health insurers posted 30.69% growth in the period, according to data released by the General Insurance Council.

India’s non-life insurance industry recorded 8.92% growth in gross direct premium to Rs 1.8 lakh crore during April-September 2026, even as a sharp contraction in premiums written by specialised insurers, particularly the agriculture insurance segment, weighed on the overall growth rate, according to provisional data released by the General Insurance Council . Excluding specialised insurers, the industry’s premium growth was significantly stronger at 11.74%, with gross direct premium rising to Rs 1.76 lakh crore from Rs 1.58 lakh crore in the corresponding period last year. In September alone, non-specialised insurers reported a 15.01% increase in premium to Rs 30,820 crore. Advt

12% from Rs 31,052 crore a year earlier. 65 lakh crore in the year-ago period. Health insurance emerges as key growth engine Standalone health insurers continued to significantly outperform the broader non-life insurance market. 69% growth in gross direct premium during April-September, taking premiums to Rs 25,586 crore from Rs 19,578 crore a year earlier. 23% to Rs 6,193 crore during the period. 35% growth to Rs 4,634 crore.



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.